Ran Liao

1.2k total citations
29 papers, 309 citations indexed

About

Ran Liao is a scholar working on Statistics and Probability, Molecular Biology and Rheumatology. According to data from OpenAlex, Ran Liao has authored 29 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Statistics and Probability, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Ran Liao's work include Statistical Methods in Clinical Trials (6 papers), Advanced Causal Inference Techniques (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Ran Liao is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Advanced Causal Inference Techniques (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Ran Liao collaborates with scholars based in United States, China and United Kingdom. Ran Liao's co-authors include Xing Lin Feng, Yaqian Liu, Tsutomu Takeuchi, Yi‐Ming Chen, Kevin Winthrop, Josef S Smolen, Athimalaipet V Ramanan, Pierre Quartier, Stuart Keller and Catherine Guly and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Annals of the Rheumatic Diseases.

In The Last Decade

Ran Liao

25 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Liao United States 9 64 56 51 47 43 29 309
Sabas Carlos Vieira Brazil 10 25 0.4× 65 1.2× 34 0.7× 64 1.4× 53 1.2× 71 410
Brian D. Modena United States 13 52 0.8× 73 1.3× 38 0.7× 176 3.7× 206 4.8× 26 770
Juliana Berk-Krauss United States 8 27 0.4× 60 1.1× 102 2.0× 79 1.7× 18 0.4× 17 463
Pascale Daniel Germany 11 36 0.6× 26 0.5× 12 0.2× 33 0.7× 27 0.6× 16 437
Ying‐Ming Chiu Taiwan 11 144 2.3× 98 1.8× 20 0.4× 38 0.8× 17 0.4× 28 363
Antonio Puglisi Guerra Italy 9 49 0.8× 31 0.6× 79 1.5× 14 0.3× 31 0.7× 15 356
Jeroen S. Kloover Netherlands 12 16 0.3× 141 2.5× 15 0.3× 71 1.5× 162 3.8× 21 523
Lawrence Liu United States 10 51 0.8× 80 1.4× 5 0.1× 207 4.4× 54 1.3× 40 414
C Sgro France 9 10 0.2× 55 1.0× 19 0.4× 94 2.0× 77 1.8× 53 422
Luis Dehesa Spain 10 44 0.7× 63 1.1× 132 2.6× 63 1.3× 17 0.4× 24 351

Countries citing papers authored by Ran Liao

Since Specialization
Citations

This map shows the geographic impact of Ran Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Liao more than expected).

Fields of papers citing papers by Ran Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Liao. The network helps show where Ran Liao may publish in the future.

Co-authorship network of co-authors of Ran Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Liao. A scholar is included among the top collaborators of Ran Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Liao. Ran Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aronne, Louis J., Naveed Sattar, Deborah B. Horn, et al.. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity (SURMOUNT-4). Diabetologie und Stoffwechsel. 19(S 01). S84–S85. 5 indexed citations
2.
Han, Qing, L Zhang, & Ran Liao. (2024). Diagnostic and prognostic significance of miR-320a-3p in patients with chronic heart failure. BMC Cardiovascular Disorders. 24(1). 308–308. 2 indexed citations
4.
Wang, Ming, et al.. (2024). Clinical Significance and Potential Mechanism of Circ_00008842 in Acute Myocardial Infarction. International Heart Journal. 65(4). 703–712. 4 indexed citations
5.
Buenconsejo, Joan, Ran Liao, Pritibha Singh, et al.. (2023). Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics. Contemporary Clinical Trials. 132. 107292–107292.
6.
Ling, Wenwu, et al.. (2022). Biomimetic photosensitizer nanocrystals trigger enhanced ferroptosis for improving cancer treatment. Journal of Controlled Release. 352. 1116–1133. 27 indexed citations
7.
Liao, Ran, et al.. (2022). Dynamic incorporation of real world evidence within the framework of adaptive design. Journal of Biopharmaceutical Statistics. 32(6). 986–998. 3 indexed citations
10.
Chakladar, Sujatro, Ran Liao, William Michael Landau, Margaret Gamalo, & Yanping Wang. (2021). Discrete Time Multistate Model With Regime Switching for Modeling COVID-19 Disease Progression and Clinical Outcomes. Statistics in Biopharmaceutical Research. 14(1). 52–66. 3 indexed citations
11.
Liao, Ran, et al.. (2021). Factors affecting health care users’ first contact with primary health care facilities in north eastern China, 2008–2018. BMJ Global Health. 6(2). e003907–e003907. 23 indexed citations
12.
Wang, Ying, Ran Liao, & Xing Lin Feng. (2020). Equity in Essential Maternal, Newborn, and Child Health Interventions in Northeastern China, 2008 to 2018. Frontiers in Public Health. 8. 212–212. 3 indexed citations
13.
Chen, Li‐Da, et al.. (2020). The role of ferroptosis in chronic intermittent hypoxia-induced liver injury in rats. Sleep And Breathing. 24(4). 1767–1773. 39 indexed citations
14.
Natanegara, Fanni, Névine Zariffa, Joan Buenconsejo, et al.. (2020). Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics. Statistics in Biopharmaceutical Research. 14(1). 5–21. 6 indexed citations
15.
Liao, Ran, Tianle Hu, & Sujuan Gao. (2020). Estimation of covariate effects in proportional cross-ratio model of bivariate time-to-event outcomes. Communications in Statistics - Simulation and Computation. 51(12). 7472–7486. 1 indexed citations
16.
Harigai, Masayoshi, Kevin Winthrop, Tsutomu Takeuchi, et al.. (2020). Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. RMD Open. 6(1). e001095–e001095. 56 indexed citations
17.
Huizinga, T., Jonathan Kay, Masayoshi Harigai, et al.. (2018). e48 Effects of baricitinib on haematological laboratory parameters in patients with rheumatoid arthritis. Lara D. Veeken. 57(suppl_3). 3 indexed citations
18.
Unverzagt, Frederick W., Ann Marie Hake, Ran Liao, et al.. (2016). Nail Selenium Level and Diabetes in Older People in Rural China.. PubMed. 29(11). 818–824. 15 indexed citations
19.
Liao, Ran, et al.. (2015). Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C. Oncology Letters. 10(4). 2422–2426. 1 indexed citations
20.
Jia, Zhenbao, Chun Hao, Yi‐Ping Huang, et al.. (2014). Outbreak of extrapulmonary tuberculosis infection associated with acupuncture point injection. Clinical Microbiology and Infection. 21(4). 349–353. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026